CADL
Candel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.85
−4.32%0
Insider buys (3m)
5
Insider sells (3m)
-$3.6M
Net value (3m)
+18.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Tak Paul Peter · director, officer: Chief Executive Officer | M-Exempt | 125,000 | $1.55 |
| Sep 11, 2026 | Tak Paul Peter · director, officer: Chief Executive Officer | Sale | 220,866 | $11 |
| Sep 11, 2026 | Tak Paul Peter · director, officer: Chief Executive Officer | Sale | 59,379 | $10 |
| Sep 10, 2026 | Zimmermann Martine · director | A-Award | 64,000 | $13 |
| Aug 19, 2026 | Tyagarajan Seshu · officer: Chief Technology Officer | Sale | 7,000 | $12 |
| Jul 8, 2026 | Sims Mark E. · officer: Chief Commercial Officer | A-Award | 285,000 | $10 |
| Jul 1, 2026 | PAPA JOSEPH C · director | A-Award | 1,331 | $10 |
| Jul 1, 2026 | Tyagarajan Seshu · officer: Chief Technology Officer | Sale | 7,000 | $10 |
| Jul 1, 2026 | Barone Francesca · officer: Chief Scientific Officer | Sale | 23,447 | $10 |
| Jul 1, 2026 | Loggia Nicoletta · director | A-Award | 381 | $10 |
| Jul 1, 2026 | Manning Paul B · director | A-Award | 2,199 | $10 |
| Jun 24, 2026 | Manning Paul B · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | PAPA JOSEPH C · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Radhakrishnan Maha · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Benz Edward J. JR · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Loggia Nicoletta · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Martell Christopher · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Gaeta Renee · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Nabel Gary J. · director | A-Award | 32,000 | $9.08 |
| Jun 24, 2026 | Nguyen Diem · director | A-Award | 32,000 | $9.08 |
| Apr 2, 2026 | Loggia Nicoletta · director | A-Award | 779 | $4.90 |
| Apr 2, 2026 | Manning Paul B · director | A-Award | 4,618 | $4.90 |
| Apr 2, 2026 | PAPA JOSEPH C · director | A-Award | 2,795 | $4.90 |
| Feb 26, 2026 | Manning Paul B · director | Purchase | 550,458 | $5.45 |
| Jan 28, 2026 | Barone Francesca · officer: Chief Scientific Officer | A-Award | 232,000 | $6.01 |
| Jan 28, 2026 | Tyagarajan Seshu · officer: Chief Technology Officer | A-Award | 154,000 | $6.01 |
| Jan 28, 2026 | Tak Paul Peter · director, officer: Chief Executive Officer | A-Award | 629,000 | $6.01 |
| Jan 28, 2026 | Schoch Charles · officer: Chief Financial Officer | A-Award | 232,000 | $6.01 |
| Jan 28, 2026 | Nichols William Garrett · officer: Chief Medical Officer | A-Award | 136,500 | $6.01 |
| Jul 30, 2025 | Nichols William Garrett · officer: Chief Medical Officer | M-Exempt | 937 | $1.29 |
Institutional positioning
13F filings over the trailing two quarters
New 79Increased 105Reduced 47Sold out 13
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 10,990,535 | Aug 13, 2026 |
| FMR LLC | Increased | 10,987,017 | May 15, 2026 |
| RTW INVESTMENTS, LP | New Position | 6,422,018 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 6,422,018 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 4,969,040 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 3,549,823 | Aug 7, 2026 |
| ACORN CAPITAL ADVISORS, LLC | Increased | 3,497,948 | May 15, 2026 |
| ACORN CAPITAL ADVISORS, LLC | Unchanged | 3,497,948 | Aug 14, 2026 |
| Portolan Capital Management, LLC | Increased | 3,490,398 | Aug 14, 2026 |
| Saturn V Capital Management LP | Increased | 3,303,686 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 3,109,042 | May 13, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | New Position | 2,896,588 | May 15, 2026 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | Increased | 2,894,325 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,694,040 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,462,757 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 11, 2026